Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease
Magnesium Oral Supplementation to Reduce Pain in Patients With Severe Peripheral Arterial Occlusive Disease: The MAG-PAPER Randomized Clinical Trial
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
A NA clinical study on Peripheral Arterial Disease, this trial is ongoing. The trial is conducted by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
May 2020 — Jan 2021 [monthly]
Unknown Status NA
-
Jun 2018 — May 2020 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.